Showing results (31-40 of 49) with videos related to
Sort By:
Pageof 5
Hepatology (Baltimore, Md.)|March 26, 2013
Inflammation-induced hepatocellular carcinoma is dependent on CCR5 in miceNeta Barashi, Ido D Weiss, Ori Wald, et al.Experimental Hematology|December 9, 2010
CXCR4 antagonist 4F-benzoyl-TN14003 inhibits leukemia and multiple myeloma tumor growthKatia Beider, Michal Begin, Michal Abraham, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2016
The Sphingosine-1-Phosphate Modulator FTY720 Targets Multiple Myeloma via the CXCR4/CXCL12 PathwayKatia Beider, Evgenia Rosenberg, Hanna Bitner, et al.Biochemical Pharmacology|July 21, 2019
The mTOR inhibitor everolimus overcomes CXCR4-mediated resistance to histone deacetylase inhibitor panobinostat through inhibition of p21 and mitotic regulatorsKatia Beider, Hanna Bitner, Valeria Voevoda-Dimenshtein, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2017
Single Dose of the CXCR4 Antagonist BL-8040 Induces Rapid Mobilization for the Collection of Human CD34+ Cells in Healthy VolunteersMichal Abraham, Yaron Pereg, Baruch Bulvik, et al.Scientific Reports|April 19, 2018
Attenuated DNA damage responses and increased apoptosis characterize human hematopoietic stem cells exposed to irradiationShahar Biechonski, Leonid Olender, Adi Zipin-Roitman, et al.European Journal of Immunology|March 30, 2004
Involvement of the CXCL12/CXCR4 pathway in the advanced liver disease that is associated with hepatitis C virus or hepatitis B virusOri Wald, Orit Pappo, Rifaat Safadi, et al.Cancer Research|December 21, 2017
CXCR4 Promotes Neuroblastoma Growth and Therapeutic Resistance through miR-15a/16-1-Mediated ERK and BCL2/Cyclin D1 PathwaysShiri Klein, Michal Abraham, Baruch Bulvik, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2013
The high-affinity CXCR4 antagonist BKT140 is safe and induces a robust mobilization of human CD34+ cells in patients with multiple myelomaAmnon Peled, Michal Abraham, Irit Avivi, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2006
IFN-gamma acts on T cells to induce NK cell mobilization and accumulation in target organsOri Wald, Ido D Weiss, Hanna Wald, et al.Pageof 5